For example, activation of glucagon family receptors (GLP1R, GIPR, GCGR) shows therapeutic efficacy in treating type-2 diabetes and obesity [49]; however, these receptors are expressed in multiple tissues [50]. Here, GIPR is linked to type 2 diabetes mellitus.